Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × Thyroxine × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2 1

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hypothyroidism 1

Interventions

Cisplatin 86 Carboplatin 83 pembrolizumab 81 Gemcitabine 69 Paclitaxel 66 Docetaxel 63 Capecitabine 48 Oxaliplatin 45 Fluorouracil 45 Radiotherapy 44 Specimen Handling 43 Bevacizumab 41 Magnetic Resonance Spectroscopy 40 Cyclophosphamide 37 Dexamethasone 36 Pemetrexed 35 Drug Therapy 35 Leucovorin 33 Doxorubicin 32 Irinotecan 30 Rituximab 27 Lenalidomide 25 Injections 25 Vincristine 24 Trastuzumab 24 toripalimab 21 Radiosurgery 21 Radiation 21 Prednisone 21 Letrozole 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05316922 2023-12-06

WIN-HYPO2021

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 3 Recruiting

Hypothyroidism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡